IBDEI0M5 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22332,0)
 ;;=C79.70^^89^1046^106
 ;;^UTILITY(U,$J,358.3,22332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22332,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,22332,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,22332,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,22333,0)
 ;;=C78.00^^89^1046^139
 ;;^UTILITY(U,$J,358.3,22333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22333,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,22333,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,22333,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,22334,0)
 ;;=D57.1^^89^1046^182
 ;;^UTILITY(U,$J,358.3,22334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22334,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,22334,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,22334,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,22335,0)
 ;;=D75.1^^89^1046^180
 ;;^UTILITY(U,$J,358.3,22335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22335,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,22335,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,22335,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,22336,0)
 ;;=C90.30^^89^1046^183
 ;;^UTILITY(U,$J,358.3,22336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22336,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,22336,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,22336,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,22337,0)
 ;;=D56.3^^89^1046^184
 ;;^UTILITY(U,$J,358.3,22337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22337,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,22337,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,22337,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,22338,0)
 ;;=D56.9^^89^1046^185
 ;;^UTILITY(U,$J,358.3,22338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22338,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,22338,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,22338,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,22339,0)
 ;;=M31.1^^89^1046^187
 ;;^UTILITY(U,$J,358.3,22339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22339,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,22339,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,22339,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,22340,0)
 ;;=D51.2^^89^1046^188
 ;;^UTILITY(U,$J,358.3,22340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22340,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,22340,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,22340,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,22341,0)
 ;;=D05.92^^89^1046^35
 ;;^UTILITY(U,$J,358.3,22341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22341,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,22341,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,22341,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,22342,0)
 ;;=D05.91^^89^1046^37
 ;;^UTILITY(U,$J,358.3,22342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22342,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,22342,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,22342,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,22343,0)
 ;;=D05.90^^89^1046^33
 ;;^UTILITY(U,$J,358.3,22343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22343,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,22343,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,22343,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,22344,0)
 ;;=D51.0^^89^1046^189
 ;;^UTILITY(U,$J,358.3,22344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22344,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,22344,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,22344,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,22345,0)
 ;;=D51.1^^89^1046^190
 ;;^UTILITY(U,$J,358.3,22345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22345,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,22345,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,22345,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,22346,0)
 ;;=D51.9^^89^1046^192
 ;;^UTILITY(U,$J,358.3,22346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22346,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,22346,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,22346,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,22347,0)
 ;;=D68.0^^89^1046^194
 ;;^UTILITY(U,$J,358.3,22347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22347,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,22347,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,22347,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,22348,0)
 ;;=C88.0^^89^1046^195
 ;;^UTILITY(U,$J,358.3,22348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22348,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,22348,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,22348,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,22349,0)
 ;;=C91.02^^89^1046^3
 ;;^UTILITY(U,$J,358.3,22349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22349,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,22349,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,22349,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,22350,0)
 ;;=C92.02^^89^1046^6
 ;;^UTILITY(U,$J,358.3,22350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22350,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,22350,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,22350,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,22351,0)
 ;;=D09.3^^89^1046^45
 ;;^UTILITY(U,$J,358.3,22351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22351,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,22351,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,22351,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,22352,0)
 ;;=C22.0^^89^1046^86
 ;;^UTILITY(U,$J,358.3,22352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22352,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,22352,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,22352,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,22353,0)
 ;;=C24.9^^89^1046^110
 ;;^UTILITY(U,$J,358.3,22353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22353,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,22353,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,22353,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,22354,0)
 ;;=C50.922^^89^1046^134
 ;;^UTILITY(U,$J,358.3,22354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22354,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,22354,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,22354,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,22355,0)
 ;;=C34.91^^89^1046^152
 ;;^UTILITY(U,$J,358.3,22355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22355,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,22355,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,22355,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,22356,0)
 ;;=C50.921^^89^1046^156
 ;;^UTILITY(U,$J,358.3,22356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22356,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,22356,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,22356,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,22357,0)
 ;;=C90.02^^89^1046^167
 ;;^UTILITY(U,$J,358.3,22357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22357,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,22357,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,22357,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,22358,0)
 ;;=D51.9^^89^1046^25
 ;;^UTILITY(U,$J,358.3,22358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22358,1,3,0)
 ;;=3^Anemia in Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,22358,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,22358,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,22359,0)
 ;;=C79.51^^89^1046^30
 ;;^UTILITY(U,$J,358.3,22359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22359,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,22359,1,4,0)
 ;;=4^C79.51
